Effectiveness and Safety of PD-1 Inhibitors’ Treatment for Patients with Non-Small-Cell Lung Cancer in China: A Real-World Study

Ning Wan; Yongbang Chen; Liqing Lu; Bing Wang; Liuliu He; Hongyi Liang; Fei Xie; Xiaoshun Jian; Bo Ji; Jianping Zhang; Ning Wan; Yongbang Chen; Liqing Lu; Bing Wang; Liuliu He; Hongyi Liang; Fei Xie; Xiaoshun Jian; Bo Ji; Jianping Zhang

doi:10.1155/2024/6004679

2024 Volume 2024

Article Contents

Next Previous

RESEARCH ARTICLE Open Access

Effectiveness and Safety of PD-1 Inhibitors’ Treatment for Patients with Non-Small-Cell Lung Cancer in China: A Real-World Study

More Information

Published online: 19 March 2024
European Journal of Cancer Care 2024, Article number: 10.1155/2024/6004679 (2024) | Cite this article

Rights and permissions
Copyright: © 2024 by the author(s). Exclusive Licensee Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.

About this article

Cite this article

Ning Wan, Yongbang Chen, Liqing Lu, Bing Wang, Liuliu He, Hongyi Liang, Fei Xie, Xiaoshun Jian, Bo Ji, Jianping Zhang. 2024. Effectiveness and Safety of PD-1 Inhibitors’ Treatment for Patients with Non-Small-Cell Lung Cancer in China: A Real-World Study. European Journal of Cancer Care. 2024: doi: 10.1155/2024/6004679

Ning Wan, Yongbang Chen, Liqing Lu, Bing Wang, Liuliu He, Hongyi Liang, Fei Xie, Xiaoshun Jian, Bo Ji, Jianping Zhang. 2024. Effectiveness and Safety of PD-1 Inhibitors’ Treatment for Patients with Non-Small-Cell Lung Cancer in China: A Real-World Study. European Journal of Cancer Care. 2024: doi: 10.1155/2024/6004679

Download PDF

Article Metrics

Article views(20) PDF downloads(21)